Cannabis-based medicines developer Celadon Pharmaceuticals (LON: CEL) remains in talks with an investor that was going to subscribe £1m in four tranches at 105p/share, but only £600,000 has been received. This leaves the company short of funds. An additional £200,000 has been received as a draw down from the committed credit facility with the other […]

The post AIM movers: Celadon Pharmaceuticals receives more cash and Thor Explorations costs fall appeared first on UK Investor Magazine.

Oxford BioDynamics (LON: OBD) continues to rise on the back of the faster than expected completion of the validation of the PSE prostate cancer test in US CLIA laboratories. The test is available in the US and the UK, which will initially send the test to be processed in the US while accreditation is obtained […]

The post AIM movers: Saietta gains contract in India and Tasty decline appeared first on UK Investor Magazine.

Recruitment software developer Dillistone Group (LON: DSG) says that executive search software product Talentis is gaining momentum with first quarter recurring revenues double the level in the fourth quarter of 2021. It should double again in this quarter. This is from a low base because it is a new product. Dillistone is still expected to […]

The post AIM movers: Dillistone, Redx Pharma, Saietta, AssetCo, SpaceandPeople appeared first on UK Investor Magazine.